is semaglutide a biologic new study from UC San Diego offers early clinical evidence that semaglutide, a widely used GLP-1 receptor agonist, may slow biological aging. In a randomized, placebo-controlled trial, researchers observed a 9% Semaglutide for Weight Loss: A

Schedule a protocol, log a dose, or record an as-needed shot without rebuilding the calculator math from scratch

P = .002)

Skipping Basics Backfires : Ignoring sleep, hydration, or balanced eating will only make things harder

Maintaining dietary modifications and physical activity established during treatment can help mitigate weight regain

( 10.1016/S0140-6736(1931271-1) [DOI] [PubMed] [Google Scholar] 107.Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Kber LV, Lawson FC, Ping L, Wei X, Lewis EFet al

Unimolecular peptides with dual GIP/GLP-1 receptor agonism have been developed to improve metabolic efficacy and therapeutic index beyond what incretin mono-agonists can achieve (44, 63)